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Chicken interferon-α administered perorally in drink-
ing water acts on the oropharyngeal mucosal system as an 
adjuvant that causes chickens to rapidly seroconvert after 
natural infection by low-pathogenicity Inﬂ  uenza virus. These 
chickens, termed super sentinels, can serve as sensitive 
early detectors of clinically inapparent infections.
E
arly detection of low-pathogenicity type A inﬂ  uenza 
virus (LPAI) circulating among chickens is impor-
tant for 3 reasons: 1) these are the most prevalent strains 
in nature and can cause substantial losses for commercial 
poultry producers (1), 2) these strains can contribute ge-
netic material to high-pathogenicity type A inﬂ  uenza virus 
(HPAI) (2), and 3) the H5 and H7 LPAI strains can mutate 
to HPAI with catastrophic effects in birds and with the po-
tential for transmission to humans with lethal consequences 
(3). Kuiken et al. reported that an HPAI (H7N7) isolate was 
observed in February 2003 in the Netherlands, which most 
likely originated in free-living ducks and had evolved into 
a highly pathogenic variant after introduction into poul-
try farms (4). Although subsequent serologic screening of 
poultry showed that the H7 inﬂ  uenza virus had been affect-
ing the Dutch poultry industry several months before the 
major epidemic, its presence had not been recognized (4). 
Our study addresses this problem by using a novel method 
that causes chickens to seroconvert under conditions in 
which LPAI would otherwise go undetected. This report 
shows that recombinant chicken interferon-α (rChIFN-α) 
(5) administered perorally in drinking water (6) acts as an 
adjuvant to produce a super-sentinel chicken that is a sensi-
tive and early detector of clinically inapparent LPAI.
The Study
In 2003, the ﬁ  rst clue to an aberrant condition in a com-
mercial ﬂ  ock of laying hens in Connecticut was signaled by 
a drop in feed consumption and then in egg production. It 
took 6–7 weeks from the time tracheal samples were sent 
to a diagnostic laboratory to conﬁ  rm the diagnosis of LPAI 
(H7N2) infection at National Veterinary Services Labora-
tory (NVSL) (N. Adriatico, pers. comm.). One such iso-
late, A/CK/CT/72/2003(H7N2), was obtained from the US 
Department of Agriculture, NVSL, Ames, Iowa, and used 
throughout this study to determine whether the peroral ad-
ministration of rChIFN-α under conditions found to ame-
liorate Newcastle disease (6), infectious bronchitis (7), and 
infectious bursal disease (8), would similarly affect avian 
inﬂ  uenza. We reasoned that if the spread of LPAI could 
be slowed or prevented, the probability of its mutating to 
HPAI would be proportionately reduced, thereby lowering 
the chances of transmission to humans. In the course of this 
study, we observed a strong adjuvant effect of rChIFN-α ad-
ministered in drinking water under conditions of virus trans-
mission that mimic natural infection in chickens. This led to 
the concept of the super-sentinel chicken described here.
Three-week-old speciﬁ  c-pathogen-free (SPF) white leg-
horns (Charles River Speciﬁ  c Pathogen Free Avian Supplies 
[SPFAS], Inc., Storrs, CT, USA) were tagged and divided 
into 2 groups of 10 chickens each. Two birds in each group 
were overtly infected intravenously or intranasally with 106 
infectious particles, measured as plaque-forming particles in 
primary chicken kidney cells (Charles River SPAFAS, Inc.). 
This strain of LPAI (H7N2) required a high inoculum to en-
sure infection (data not shown), comparable to that reported 
for another LPAI (H7N2) strain evaluated in SPF chickens 
(9). The 8 remaining cage mates in each group served as sen-
tinel birds naturally subject to infection by the respiratory 
tract, ingestion of fecal material, or both. One group of birds 
received plain drinking water; the other group received drink-
ing water that contained 2,000 U/mL rChIFN-α. The water 
was provided ad libitum and changed daily. Water consump-
tion was the same in both groups, as determined from the 
amount remaining after a known volume was provided each 
day (data not shown). With a half-life of 3–5 days in water at 
room temperature (6), this concentration of interferon (IFN) 
delivered an average dose of ≈3 × 105 U rChIFN-α/bird/day. 
Fourteen days post overt infection (dpi), the rChIFN-α-water 
was replaced with plain water for the remaining 14 days of 
the study. This dose of rChIFN-α was sufﬁ  cient to amelio-
rate Newcastle disease (6).
Following overt infection of 2 birds per cage, and the 
natural cross-infection of the 8 cage mates, serum samples 
were taken from each of the 10 birds at the intervals in-
dicated in Figure 1. This ﬁ  gure shows data from 2 inde-
pendent studies that used agar gel precipitin (AGP) tests to 
detect antibody against avian inﬂ  uenza virus nucleoprotein 
and M1 antigens. This qualitative test demonstrated that of 
the 16 naturally infected chickens given plain water, none 
seroconverted over the 28-day period they were exposed 
to the 2 infected cage mates. In marked contrast, of the 16 
naturally infected chickens given water containing IFN, 14 
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were seropositive by 14 dpi and remained so during the 
28-day test period.
Figure 2 shows the number of seroconverted birds in 
a third study as quantiﬁ  ed by hemagglutination inhibition 
(HI) titer (HI U/mL) of serum samples taken at the time 
intervals indicated as dpi. None of the 8 naturally infected 
birds given plain water seroconverted during the 28 days of 
the trial. In contrast, the 8 naturally infected chickens raised 
on IFN-water all seroconverted by 10 dpi (8/8), as did the 
overtly infected birds. Similar results were observed in 2 
other trials. In all, 4 independent comparable trials were 
conducted, representing 2 AGP and 2 HI tests (Table 1). 
The marked contrast in the fraction of naturally infected 
birds that seroconverted on plain water and IFN-water is 
evident.
Although the sensitivity of LPAI to the action of IFN is 
well documented (10,11), rChIFN-α in the drinking water 
may have been exacerbating the infection, thereby leading 
to high levels of virus and antigen and high levels of sero-
conversion. This possibility was tested by using quantita-
tive real-time reverse transcriptase–PCR to determine the 
amount of avian inﬂ  uenza virus in tracheal samples at 2, 
4, and 10 dpi. Table 2 shows that within the error expected 
from testing individual chickens, the amount of infectious 
particle equivalents were not signiﬁ  cantly different in birds 
given plain water or IFN-water. Thus, that more avian in-
ﬂ  uenza virus antigen was produced in chickens that were 
given IFN-water is an unlikely explanation.
Conclusions
Although the role of IFN as an adjuvant when deliv-
ered perorally has been established in mammals (12), our 
data demonstrate for the ﬁ  rst time, to our knowledge, that 
avian IFN administered in drinking water to naturally in-
fected chickens lowers the threshold of antigen required to 
stimulate the adaptive immune response to an LPAI iso-
late. As a consequence, the action of perorally administered 
rChIFN-α in effect creates super-sentinel chickens that se-
roconvert in response to levels of antigen that would oth-
erwise go undetected. Super-sentinel chickens would thus 
provide a novel means of detecting otherwise inapparent 
infections of LPAI, thereby buying time for its control or 
eradication.
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Figure 1. Seroconversion in speciﬁ  c-pathogen-free white leghorns 
after infection with inﬂ  uenza A/CK/CT/72/2003 (H7N2) as measured 
by agar gel precipitin (AGP) tests for avian inﬂ  uenza virus nucleo-
protein and M1 antigens. Each box represents 1 chicken; (–), 
water; (+), water plus recombinant chicken interferon-α at 2,000 
U/mL. IFN, interferon; IN, intranasal; IV, intravenous. A and B are 
independent trials. Serum samples were obtained at the times 
indicated on days post infection for overtly infected birds.
Figure 2. Seroconversion in sentinel speciﬁ  c-pathogen-free white 
leghorns after natural infection with inﬂ  uenza  A/CK/CT/72/03 
(H7N2) from overtly infected birds as quantiﬁ  ed by hemagglutination 
inhibition (HI) tests for hemagglutinin (HA) antigen. The titer in HI 
U/mL is plotted as a function of days post overt infection  of 2 birds 
in each group. The key is similar to that of Figure 1, except the 
assay is for HI. A, water only; B, water plus recombinant chicken 
interferon-α at 2,000 U/mL. Results of 1 trial are shown; 2 other 
trials gave similar results.
Table 1. Seroconversion in influenza A virus–infected 3-week-old 
chickens given water or water + interferon* 
No. chickens 
Infection type†  Water 
Water + 
interferon‡ Total 
Overtly infected  4/8§ 8/8 16
Sentinel 2/32 31/31 63
Combined 6/40 39/39 79
*Represents 4 independent trials. 
†Overtly infected birds were mixed with uninfected sentinel cage mates, 
the latter to become infected naturally. 
‡Recombinant chicken interferon-α at 2,000 U/mL (5). 
§No. positive birds/total no. receiving  treatment, scored by agar gel 
precipitin or hemagglutination inhibition tests. DISPATCHES
We envision the introduction into a large ﬂ  ock of a 
number of small cages containing chickens in which IFN-
water replaces plain water. These super-sentinel chickens 
will serve as sensitive early detectors of LPAI, like the pro-
verbial canary used in mines to detect low levels of toxic 
gases. Because of the cross-reaction between chicken and 
turkey IFN-α (5,13), super-sentinel turkeys could likely be 
created in a similar manner. Super-sentinel birds could be 
replaced every month and possibly returned to production.
All strains of chickens tested, including those in the 
People’s Republic of China, have proved to be sensitive to 
the action of rChIFN-α (14). Genetically engineered pro-
duction of rChIFN-α (15), treatment with it optimized for 
dose and duration, and its long half-life in water may make 
it economically feasible to convert many birds in a ﬂ  ock to 
super-sentinel status. It also may be prudent to set up super-
sentinel birds in areas of high risk for avian inﬂ  uenza virus 
outbreaks, such as live-bird markets. Surveillance of other 
families of birds might be possible with species-speciﬁ  c 
IFN. Further studies are required to test these possibilities 
and the extent to which rChIFN-α functions as an adjuvant 
with other strains of avian inﬂ  uenza virus and chickens.
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Table 2. Influenza A virus infectious particle equivalents (IPE) in 
tracheal swabs from sentinel chickens given water or water + 
interferon and infected naturally* 
Day postinfection  Water (IPE/mL) 
Water + interferon† 
(IPE/mL)
2 1,112 ± 1,353‡  760 ± 632 
4 1,234 ± 764  463 ± 484 
10 1,325 ± 398  2,113 ± 1,834 
*Each cage contained 2 overtly infected birds and 8 cage mates as 
sentinels. Only sentinel birds are reported. Chickens were 3 weeks old at 
the start. 
†Recombinant chicken interferon-α in water at 2,000 U/mL (5). 
‡Mean ± SD, n = 8. Quantitative real-time reverse transcriptase–PCR 
analysis with influenza A virus standard: IPE/mL. 